OBJECTIVE: Autism Spectrum Disorder is a complex brain disorder and has multiple causes that occur in diverse combinations. There is a need to classify children with ASD at a very young age so that they can access evidence-based intervention that can significantly improve their outcomes.
CASE REPORT: In this report we present a case of autism, which underwent intrathecal autologous bone marrow mononuclear cells transplantation along with neurorehabilitation. The primary goal of the treatment is to improve the quality of life of the patient. After the procedure, the child started to speak, therefore, the third communication subscale was scored within the GARS-2 assessment instrument. With these three subscales, a score of 91 has been achieved, representing an autism index of 27%, a significant improvement over the previous score.
CONCLUSIONS: Our study demonstrated evidences to support the safety and effectiveness of BMAC transplantation in the management of autism.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
D.M. Maric, V. Papic, M. Radomir, I. Stanojevic, I. Sokolovac, K. Milosavljevic, D.L. Maric, D. Abazovic
Autism treatment with stem cells: a case report
Eur Rev Med Pharmacol Sci
Vol. 24 - N. 15